REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal

被引：0
|
作者：
S. Batista
C. C. Nunes
J. J. Cerqueira
Ana Martins Silva
J. Correia de Sá
J. Ferreira
M. T. Mendonça
J. Pinheiro
V. Salgado
A. S. Correia
J. Sequeira
A. Costa
L. Sousa
机构：
[1] Centro Hospitalar e Universitário de Coimbra,School of Medicine
[2] Hospital de Braga,Unidade Multidisciplinar Investigação Biomédica, Instituto Ciências Biomédicas Abel Salazar
[3] University of Minho,Centro Hospitalar Lisboa Norte E.P.E.
[4] Centro Hospitalar Universitário do Porto,Centro Hospitalar de Lisboa Ocidental E.P.E.
[5] Universidade do Porto,Centro Hospitalar Universitário de Lisboa Central E.P.E.
[6] Hospital de Santa Maria,undefined
[7] Centro Hospitalar São João,undefined
[8] Centro Hospitalar Vila Nova Gaia,undefined
[9] Hospital Prof. Doutor Fernando Fonseca E.P.E.,undefined
[10] Hospital de Egas Moniz,undefined
[11] Hospital Santo António dos Capuchos,undefined
[12] Novartis Farma,undefined
来源：
Neurological Sciences | 2021年 / 42卷
关键词：
Relapsing-remitting multiple sclerosis; Real-world study; Fingolimod; ARR; EDSS; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1995 / 2003
页数：8
相关论文
共 50 条
  • [31] The comparative effectiveness of fingolimod, natalizumab, and ocrelizumab in relapsing-remitting multiple sclerosis
    Boz, Cavit
    Ozakbas, Serkan
    Terzi, Murat
    Karabudak, Rana
    Sevim, Serhan
    Turkoglu, Recai
    Soysal, Aysun
    Balci, Belgin Petek
    Efendi, Husnu
    Turan, Omer Faruk
    Yuceyar, Nur
    Yetkin, Mehmet Fatih
    Karahan, Serap Zengin
    Demirkiran, Meltem
    Guler, Sibel
    Agan, Kadriye
    Kiylioglu, Nefati
    Baba, Cavid
    Tuncer, Asli
    Koseoglu, Mesrure
    [J]. NEUROLOGICAL SCIENCES, 2023, 44 (06) : 2121 - 2129
  • [32] Predicting response to fingolimod in patients with relapsing-remitting multiple sclerosis
    Giuliani, M.
    Prosperini, L.
    Fanelli, F.
    Hirsch, M. N.
    De Angelis, F.
    Pozzilli, C.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 306 - 306
  • [33] Real-world outcomes of teriflunomide in relapsing-remitting multiple sclerosis: a prospective cohort study
    Zhang, Yao
    Yin, Hexiang
    Zhang, Dingding
    Xu, Yan
    Peng, Bin
    Cui, Liying
    [J]. JOURNAL OF NEUROLOGY, 2022, 269 (09) : 4808 - 4816
  • [34] Real-world outcomes of teriflunomide in relapsing-remitting multiple sclerosis: a prospective cohort study
    Zhang, Y.
    Yin, H.
    Zhang, D.
    Xu, Y.
    Peng, B.
    Cui, L.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 888 - 889
  • [35] Comparative effectiveness of natalizumab and fingolimod in different subgroups of patients with relapsing-remitting multiple sclerosis
    Sharmin, S.
    Lefort, M.
    Andersen, J.
    Horakova, D.
    Havrdova, E. K.
    Alroughani, R.
    Izquierdo, G.
    Eichau, S.
    Ozakbas, S.
    Butzkueven, H.
    Patti, F.
    Onofrj, M.
    Lugaresi, A.
    Terzi, M.
    Grammond, P.
    Grand'Maison, F.
    Yamout, B.
    Prat, A.
    Girard, M.
    Duquette, P.
    Boz, C.
    Trojano, M.
    McCombe, P.
    Slee, M.
    Lechner-Scott, J.
    Turkoglu, R.
    Sola, P.
    Ferraro, D.
    Granella, F.
    Shaygannejad, V.
    Prevost, J.
    Skibina, O.
    Solaro, C.
    Karabudak, R.
    Van Wijmeersch, B.
    Csepany, T.
    Spitaleri, D.
    Vucic, S.
    Leray, E.
    Sorensen, P. S.
    Sellebjerg, F.
    Magyari, M.
    Vukusic, S.
    Kalincik, T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 786 - 788
  • [36] Fingolimod treatment in relapsing-remitting multiple sclerosis-The real-world experience at Rashid Hospital Multiple Sclerosis (MS)Center in Dubai
    Inshasi, Jihad Said
    Sarathchandran, Pournamy
    Alboudi, Ayman
    Kamal, Yasmine
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (06) : NP10 - NP10
  • [37] Real-World Use of Fingolimod in Patients with Relapsing Remitting Multiple Sclerosis: A Retrospective Study Using the National Multiple Sclerosis Registry in Kuwait
    AL-Hashel, Jasem
    Ahmed, Samar F.
    Behbehani, Raed
    Alroughani, Raed
    [J]. CNS DRUGS, 2014, 28 (09) : 817 - 824
  • [38] Real-life long-term effectiveness of fingolimod in Swiss patients with relapsing-remitting multiple sclerosis
    Zecca, C.
    Roth, S.
    Findling, O.
    Perriard, G.
    Bachmann, V.
    Pless, M. L.
    Baumann, A.
    Kamm, C. P.
    Lalive, P. H.
    Czaplinski, A.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 (05) : 762 - 767
  • [39] Real-World Use of Fingolimod in Patients with Relapsing Remitting Multiple Sclerosis: A Retrospective Study Using the National Multiple Sclerosis Registry in Kuwait
    Jasem AL-Hashel
    Samar F. Ahmed
    Raed Behbehani
    Raed Alroughani
    [J]. CNS Drugs, 2014, 28 : 817 - 824
  • [40] Fingolimod Therapy for Pediatric Relapsing-Remitting Multiple Sclerosis: A Real-Life Study
    Ilki, Canan Duman
    Gunduz, Tuncay
    Kurtuncu, Murat
    Yapici, Zuhal
    Sencer, Serra
    Eraksoy, Mefkure
    [J]. TURKISH JOURNAL OF NEUROLOGY, 2020, 26 (01) : 34 - 38
12345